AAAAAA

   
Results: 1-15 |
Results: 15
Cellular response of antioxidant metalloproteins in Cu/Zn SOD transgenic mice exposed to hyperoxia
Authors: Levy, MA Tsai, YH Reaume, A Bray, TM
Citation: Ma. Levy et al., Cellular response of antioxidant metalloproteins in Cu/Zn SOD transgenic mice exposed to hyperoxia, AM J P-LUNG, 281(1), 2001, pp. L172-L182
SB-239063, a potent and selective inhibitor of p38 map kinase: Preclinicalpharmacokinetics and species-specific reversible isomerization
Authors: Ward, KW Proksch, JW Azzarano, LM Salyers, KL McSurdy-Freed, JE Molnar, TM Levy, MA Smith, BR
Citation: Kw. Ward et al., SB-239063, a potent and selective inhibitor of p38 map kinase: Preclinicalpharmacokinetics and species-specific reversible isomerization, PHARM RES, 18(9), 2001, pp. 1336-1344
Development of an in vivo preclinical screen model to estimate absorption and bioavailability of xenobiotics
Authors: Ward, KW Proksch, JW Levy, MA Smith, BR
Citation: Kw. Ward et al., Development of an in vivo preclinical screen model to estimate absorption and bioavailability of xenobiotics, DRUG META D, 29(1), 2001, pp. 82-88
Preclinical pharmacokinetics of SB-203580, a potent inhibitor of p38 mitogen-activated protein kinase
Authors: Ward, KW Proksch, JW Azzarano, LM Mumaw, JA Roethke, TJ Stelman, GJ Walsh, MJ Zeigler, KS McSurdy-Freed, JE Kehler, JR Chokshi, J Levy, MA Smith, BR
Citation: Kw. Ward et al., Preclinical pharmacokinetics of SB-203580, a potent inhibitor of p38 mitogen-activated protein kinase, XENOBIOTICA, 31(11), 2001, pp. 783-797
Potent and selective nonpeptide inhibitors of caspases 3 and 7
Authors: Lee, D Long, SA Murray, JH Adams, JL Nuttall, ME Nadeau, DP Kikly, K Winkler, JD Sung, CM Ryan, MD Levy, MA Keller, PM DeWolf, WE
Citation: D. Lee et al., Potent and selective nonpeptide inhibitors of caspases 3 and 7, J MED CHEM, 44(12), 2001, pp. 2015-2026
Inhibition of caspase-3-like activity prevents apoptosis while retaining functionality of human chondrocytes in vitro
Authors: Nuttall, ME Nadeau, DP Fisher, PW Wang, F Keller, PM DeWolf, WE Goldring, MB Badger, AM Lee, D Levy, MA Gowen, M Lark, MW
Citation: Me. Nuttall et al., Inhibition of caspase-3-like activity prevents apoptosis while retaining functionality of human chondrocytes in vitro, J ORTHOP R, 18(3), 2000, pp. 356-363
Assembly and preferential localization of Nup116p on the cytoplasmic face of the nuclear pore complex by interaction with Nup82p
Authors: Ho, AK Shen, TX Ryan, KJ Kiseleva, E Levy, MA Allen, TD Wente, SR
Citation: Ak. Ho et al., Assembly and preferential localization of Nup116p on the cytoplasmic face of the nuclear pore complex by interaction with Nup82p, MOL CELL B, 20(15), 2000, pp. 5736-5748
Evaluation of the use of accelerated infusions for the determination of pharmacokinetic linearity
Authors: Ward, KW Griffiths, R Levy, MA Smith, BR
Citation: Kw. Ward et al., Evaluation of the use of accelerated infusions for the determination of pharmacokinetic linearity, J PHARM EXP, 293(2), 2000, pp. 468-479
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality
Authors: Lee, D Long, SA Adams, JL Chan, G Vaidya, KS Francis, TA Kikly, K Winkler, JD Sung, CM Debouck, C Richardson, S Levy, MA DeWolf, WE Keller, PM Tomaszek, T Head, MS Ryan, MD Haltiwanger, RC Liang, PH Janson, CA McDevitt, PJ Johanson, K Concha, NO Chan, W Abdel-Meguid, SS Badger, AM Lark, MW Nadeau, DP Suva, LJ Gowen, M Nuttall, ME
Citation: D. Lee et al., Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality, J BIOL CHEM, 275(21), 2000, pp. 16007-16014
Potent dipeptidylketone inhibitors of the cysteine protease cathepsin K
Authors: Marquis, RW Ru, Y Yamashita, DS Oh, HJ Yen, J Thompson, SK Carr, TJ Levy, MA Tomaszek, TA Ijames, CF Smith, WW Zhao, BG Janson, CA Abdel-Meguid, SS D'Alessio, KJ McQueney, MS Veber, DF
Citation: Rw. Marquis et al., Potent dipeptidylketone inhibitors of the cysteine protease cathepsin K, BIO MED CH, 7(4), 1999, pp. 581-588
Structure-based design of non-peptide, carbohydrazide-based cathepsin K inhibitors
Authors: Thompson, SK Halbert, SM DesJarlais, RL Tomaszek, TA Levy, MA Tew, DG Ijames, CF Veber, DF
Citation: Sk. Thompson et al., Structure-based design of non-peptide, carbohydrazide-based cathepsin K inhibitors, BIO MED CH, 7(4), 1999, pp. 599-605
A substrate combinatorial array for caspases
Authors: Lee, D Adams, JL Brandt, M DeWolf, WE Keller, PM Levy, MA
Citation: D. Lee et al., A substrate combinatorial array for caspases, BIOORG MED, 9(12), 1999, pp. 1667-1672
Exploring environment-security connections
Authors: Levy, MA
Citation: Ma. Levy, Exploring environment-security connections, ENVIRONMENT, 41(1), 1999, pp. 3-3
Mechanism of inhibition of cathepsin K by potent, selective 1,5-diacylcarbohydrazides: A new class of mechanism-based inhibitors of thiol proteases
Authors: Bossard, MJ Tomaszek, TA Levy, MA Ijames, CF Huddleston, MJ Briand, J Thompson, S Halpert, S Veber, DF Carr, SA Meek, TD Tew, DG
Citation: Mj. Bossard et al., Mechanism of inhibition of cathepsin K by potent, selective 1,5-diacylcarbohydrazides: A new class of mechanism-based inhibitors of thiol proteases, BIOCHEM, 38(48), 1999, pp. 15893-15902
Synergistic effects of concurrent challenge with bovine respiratory syncytial virus and 3-methylindole in calves
Authors: Bingham, HR Morley, PS Wittum, TE Bray, TM West, KH Slemons, RD Ellis, JA Haines, DM Levy, MA Sarver, CF Saville, WJA Cortese, VS
Citation: Hr. Bingham et al., Synergistic effects of concurrent challenge with bovine respiratory syncytial virus and 3-methylindole in calves, AM J VET RE, 60(5), 1999, pp. 563-570
Risultati: 1-15 |